tsh biopharmoration Ltd (8432) — Cash Flow Quality Index
tsh biopharmoration Ltd (8432) has a Cash Flow Quality Index of 1.62x as of June 2025. Operating cash flow of NT$42.55 Million exceeds net income of NT$26.20 Million, indicating high earnings quality where cash backs reported profits. Also explore tsh biopharmoration Ltd total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
tsh biopharmoration Ltd Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for tsh biopharmoration Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tsh biopharmoration Ltd (8432) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for tsh biopharmoration Ltd (2017–2024)
Year-by-year earnings quality comparison for tsh biopharmoration Ltd. For live market cap and the full company financial profile, see tsh biopharmoration Ltd market cap and net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.62x | NT$183.77 Million | NT$113.09 Million | ▲ +265.0% |
| 2023 | 0.45x | NT$33.87 Million | NT$76.09 Million | ▲ +5.3% |
| 2022 | 0.42x | NT$34.35 Million | NT$81.24 Million | ▼ -62.1% |
| 2021 | 1.12x | NT$68.71 Million | NT$61.55 Million | ▲ +642.5% |
| 2020 | 0.15x | NT$11.61 Million | NT$77.23 Million | ▼ -85.5% |
| 2019 | 1.04x | NT$88.65 Million | NT$85.33 Million | ▼ -4.1% |
| 2018 | 1.08x | NT$62.62 Million | NT$57.78 Million | ▼ -13.2% |
| 2017 | 1.25x | NT$81.13 Million | NT$64.97 Million | — |